Document is current
Any future updates will be listed below
-
Authors
Winthrop, Kevin L.
Cohen, Stanley B.
- License Information
-
More Information
Article History
Accepted: 17 February 2022
First Online: 22 March 2022
Competing interests
: K.L.W. declares that he has acted as a consultant for AbbVie, Union AstraZeneca, Bristol Myers Squibb (BMS), Chimique Belge (UCB), Eli Lilly & Company, Galapagos, Gilead, GlaxoSmithKline, Novartis, Pfizer, Regeneron, Roche and Sanofi, and has received research funding from Bristol Myers Squibb and Pfizer. S.B.C. declares that he has acted as a consultant for and received research funding from AbbVie, Amgen, Gilead, Lilly and Pfizer.
